首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Mediterranean journal of rheumatology

缩写:

ISSN:2529-198X

e-ISSN:2529-198X

IF/分区:2.1/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引678
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Hala S Talaat,Maha F Sheba,Rehab H Mohammed et al. Hala S Talaat et al.
Background: Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disorder that is characterized by recurrent episodes of fever, peritonitis, pleuritis, pericarditis, and/or arthritis. MEFV is the ...
Christian Vassallo,Andrew A Borg,Daniel Farrugia et al. Christian Vassallo et al.
Objective/aim: Septic arthritis is an uncommon but important disease with significant morbidity and mortality, especially if inadequately managed. The aim of this epidemiological study was to identify the characteristics ...
Ifigenia Kostoglou-Athanassiou,Lambros Athanassiou,Panagiotis Athanassiou Ifigenia Kostoglou-Athanassiou
Omega-3 fatty acids are unsaturated fatty acids thought to play a role in health and disease. They are known as essential fatty acids, as they cannot be synthesized in mammals. Omega-3 fatty acids have a beneficial effect on the secondary p...
Gilheaney Órla,Sibylle Béchet,Margaret Walshe Gilheaney Órla
Objective: Individuals presenting with rheumatoid arthritis (RA) frequently experience temporomandibular disorders (TMDs), which can result in limited ranges of mandibular motion, pain and fatigue on jaw function, and imp...
Pavlos Stamatis Pavlos Stamatis
Giant cell arteritis (GCA) and Takayasu Arteritis (TAK) are two systemic granulomatous vasculitides affecting medium- and large-sized arteries. Similarities in GCA and TAK regarding the clinical presentation, the systemic inflammatory respo...
Wieland D Müskens,Sanne A A Rongen-van Dartel,Eddy M M Adang et al. Wieland D Müskens et al.
These days, the use of biosimilars for the treatment of bio-naive patients is well established. However, the transition of patients being treated with a bio-originator to its biosimilar is still a topic of discussion. The main issue is whic...